Evaluate Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Sign: Together with chemotherapy, for the treatment method of Grownup patients with regionally recurrent unresectable or metastatic triple-destructive breast cancer who may have not received prior chemotherapy for metastatic condition and whose tumours Convey programmed mobile death-ligand 1 (combined optimistic sc... https://keytrudacost37159.pages10.com/the-keytruda-cost-diaries-71121565